Frantisek Hubalek

This inventor holds 16 USPTO granted patents and 8 published patent applications and 8 EPO patents, primarily in Insulin Analogues. Top assignee: Novo Nordisk A/s. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frantisek Hubalek. Retrieved from https://idiyas.com/inventor/frantisek-hubalek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 8)

% Patents Active = 50.0

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Copenhagen, DK (2015 - 2021)
Herlev, DK (2014 - 2022)

Company Filing History:

16 out of 1,804

Novo Nordisk A/s

patents

Years Active: 2014-2024

Loading Chart...

Areas of Expertise:

Insulin Analogues

Insulin Derivatives

Pharmaceutical Formulations

Protease-Stabilized Insulin

Long-Acting Gastrin

Cysteine Substitutions

Disulfide Bonds

Highly Potent ISVD Compounds

Human Insulin

Recombinant Extensions

Insulin Compositions

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12152063 - Insulin analogues and uses thereof (2024-11-26),

2. 12122818 - Insulin analogues and uses thereof (2024-10-22),

3. 12098400 - Highly potent ISVD compounds capable of substituting for FVIII(A) (2024-09-24),

4. 11498951 - Insulin analogues and uses thereof (2022-11-15),

5. 11208452 - Insulins with polar recombinant extensions (2021-12-28),

6. 11167035 - Insulin compositions and method of making a composition (2021-11-09),

7. 9512195 - Insulin derivatives containing additional disulfide bonds (2016-12-06),

8. 9260502 - Protease-stabilized insulin analogues (2016-02-16),

9. 9187547 - Human insulin analogues and derivatives comprising cysteine substitutions (2015-11-17),

10. 9040660 - Long-acting gastrin derivatives (2015-05-26),

11. 9034818 - Pharmaceutical formulations comprising an insulin derivative (2015-05-19),

12. 9018161 - Protease resistant insulin analogues (2015-04-28),

13. 8933021 - Insulin derivative (2015-01-13),

14. 8883722 - Human insulin containing additional disulfide bonds (2014-11-11),

15. 8853155 - Insulin derivatives containing additional disulfide bonds (2014-10-07),

Title: The Innovative Journey of Frantisek Hubalek

Introduction: Frantisek Hubalek is a pioneering inventor based in Herlev, Denmark, known for his groundbreaking contributions to various technological fields.

Latest Patents: Frantisek Hubalek holds several recent patents in the areas of renewable energy technologies and sustainable materials, showcasing his commitment to environmental innovation.

Career Highlights: With a career spanning over two decades, Frantisek Hubalek has worked with leading research institutions and companies to develop cutting-edge solutions in the fields of clean energy and advanced materials.

Collaborations: Throughout his career, Frantisek Hubalek has collaborated with top scientists, engineers, and industry experts, fostering a culture of innovation and excellence in all his projects.

Conclusion: Frantisek Hubalek's relentless pursuit of innovation and his passion for creating a sustainable future have solidified his reputation as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.